2018
DOI: 10.3329/bmjk.v50i1-2.35844
|View full text |Cite
|
Sign up to set email alerts
|

Fanconi anemia

Abstract: Abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…The limitations of our research were as follows: (1) As no experiments were undertaken, our results cannot be validated; there is therefore a need for clinical molecular experiments to con rm the identi ed genes and pathways in FA. (2) The data used in this research came from publicly available databases, therefore we could not assess the quality of the data, which might have led to bias; (3) There were only a few bioinformatic tools used in this research; future research should include more bioinformatic tools and more FA datasets should be used to identify further KEGG pathways.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…The limitations of our research were as follows: (1) As no experiments were undertaken, our results cannot be validated; there is therefore a need for clinical molecular experiments to con rm the identi ed genes and pathways in FA. (2) The data used in this research came from publicly available databases, therefore we could not assess the quality of the data, which might have led to bias; (3) There were only a few bioinformatic tools used in this research; future research should include more bioinformatic tools and more FA datasets should be used to identify further KEGG pathways.…”
Section: Discussionmentioning
confidence: 97%
“…Fanconi anemia (FA) is a rare, autosomal recessive inherited disease of the circulatory system [1]. It is characterized by premature aging, serious failure of bone marrow development, and a high susceptibility to various tumors [2,3]; among them, the probability of FA patients developing acute myeloid leukemia is 700-fold that of other populations [4].…”
Section: Introductionmentioning
confidence: 99%